GSK, Theravance (THRX) Receive Approval for Breo Ellipta as COPD Treatment in Australia
Tweet Send to a Friend
Glaxo (NYSE: GSK) Australia and Theravance, Inc. (Nasdaq: THRX) announced that the Therapeutic Goods Administration (TGA) has approved Breo ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
